Medical Applications Of Research Tackled By Sixth Annual Bioethics Forum

March 27, 2007 – 7:57 pm | posted in Biology / Biochemistry, Conferences, Public Health

The interface between molecular biology, medical applications, law, religion and ethics will be the focus of the sixth annual international Bioethics Forum, hosted by Promega Corp.’s BioPharmaceutical Technology Center Institute (BTCI) in Fitchburg, Wis.

The title of this year’s conference, to be held on Thursday and Friday, April 19-20, is “From Therapy to Enhancement.” Featuring a series of keynote speakers and discussion sessions, the annual forum is designed to provide the public with access to accurate scientific information and a venue for discussing related social and ethical issues.

Confirmed keynote speakers, in order of presentation, include:

Gabriela Cezar, assistant professor, animal sciences, UW-Madison: Developing Therapeutics: From Research to Market

Andrew J. Imparato, president and CEO, American Association of People with Disabilities: Making the World Safe for Disability

Erik Parens, Associate for Philosophical Studies, The Hastings Center: Understanding the Enhancement Debate

Joe Palca, science correspondent, National Public Radio: How Do You Communicate Complexity and Uncertainty in 3 Minutes?

Maxwell Mehlman, Arthur E. Petersilge Professor of Law and director, Law-Medicine Center, Case Western Reserve University School of Law: The Social Control of Biomedical Enhancement

R. Alta Charo, Warren P. Knowles Professor of Law & Bioethics, UW-Madison: Fear and the First Amendment: Scientific Freedom, Social Disruption and the Political Expression

In addition to the keynote presentations, several discussion sessions will be held, including Student Voices; Prenatal Genetic Diagnosis: Links with the Enhancement Discussion; Novel Stem Cell Therapies: From Research to Clinic; Reflections from Diverse Faith Perspectives; How Do We Conduct Research Related to Enhancement?; Enhancement in the World of Sports.

The Bioethics Forum will take place at Promega Corporation’s BioPharmaceutical Technology Center (BTC), located at 5445 E. Cheryl Parkway in Fitchburg. The conference is open to the public and the registration fee is $75.

ShareThis